Tandem Diabetes Care Inc (TNDM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.36 is considered Undervalued compared with the five-year average of 44.42. The fair price of Tandem Diabetes Care Inc (TNDM) is between 28.11 to 121.59 according to relative valuation method. Compared to the current price of 25.23 USD , Tandem Diabetes Care Inc By Undervalued By 10.25%.

Relative Value

Fair Zone

28.11-121.59

Current Price：25.23

10.25%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Tandem Diabetes Care Inc (TNDM) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Tandem Diabetes Care Inc (TNDM) has a current Price-to-Book (P/B) ratio of 10.98. Compared to its 3-year average P/B ratio of 7.72, the current P/B ratio is approximately 42.34% higher. Relative to its 5-year average P/B ratio of 10.39, the current P/B ratio is about 5.76% higher. Tandem Diabetes Care Inc (TNDM) has a Forward Free Cash Flow (FCF) yield of approximately -1.72%. Compared to its 3-year average FCF yield of -1.53%, the current FCF yield is approximately 12.67% lower. Relative to its 5-year average FCF yield of -0.42%, the current FCF yield is about 306.60% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for TNDM competitors is 3.30, providing a benchmark for relative valuation. Tandem Diabetes Care Inc Corp (TNDM.O) exhibits a P/S ratio of 1.36, which is -58.69% above the industry average. Given its robust revenue growth of 2.74%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of TNDM increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of TNDM in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is TNDM currently overvalued or undervalued?

Tandem Diabetes Care Inc (TNDM) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.36 is considered Undervalued compared with the five-year average of 44.42. The fair price of Tandem Diabetes Care Inc (TNDM) is between 28.11 to 121.59 according to relative valuation method. Compared to the current price of 25.23 USD, Tandem Diabetes Care Inc is Undervalued By 10.25%.

What is Tandem Diabetes Care Inc (TNDM) fair value?

TNDM's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Tandem Diabetes Care Inc (TNDM) is between 28.11 to 121.59 according to relative valuation method.

How does TNDM's valuation metrics compare to the industry average?

The average P/S ratio for TNDM's competitors is 3.30, providing a benchmark for relative valuation. Tandem Diabetes Care Inc Corp (TNDM) exhibits a P/S ratio of 1.36, which is -58.69% above the industry average. Given its robust revenue growth of 2.74%, this premium appears unsustainable.

What is the current P/B ratio for Tandem Diabetes Care Inc (TNDM) as of Mar 02 2026?

As of Mar 02 2026, Tandem Diabetes Care Inc (TNDM) has a P/B ratio of 10.98. This indicates that the market values TNDM at 10.98 times its book value.

What is the current FCF Yield for Tandem Diabetes Care Inc (TNDM) as of Mar 02 2026?

As of Mar 02 2026, Tandem Diabetes Care Inc (TNDM) has a FCF Yield of -1.72%. This means that for every dollar of Tandem Diabetes Care Inc's market capitalization, the company generates -1.72 cents in free cash flow.

What is the current Forward P/E ratio for Tandem Diabetes Care Inc (TNDM) as of Mar 02 2026?

As of Mar 02 2026, Tandem Diabetes Care Inc (TNDM) has a Forward P/E ratio of -20.80. This means the market is willing to pay $-20.80 for every dollar of Tandem Diabetes Care Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Tandem Diabetes Care Inc (TNDM) as of Mar 02 2026?

As of Mar 02 2026, Tandem Diabetes Care Inc (TNDM) has a Forward P/S ratio of 1.36. This means the market is valuing TNDM at $1.36 for every dollar of expected revenue over the next 12 months.

TNDM Valuation